Table 1.
Psoriasis | Control | |
---|---|---|
n | 56 | 33 |
Age | 39.75 ± 18.29 | 36.18 ± 14.19 |
Male/female | 21/35 | 11/22 |
PASI | 8.3 ± 6.5 | |
BMI (kg/m2) | 26.7 ± 5.8 | 25.7 ± 5.1 |
Lipocalin 2 (ng/mL) | 2.54 ± 0.46** | 2.07 ± 0.39 |
Clusterin (ng/mL) | 2.55 ± 0.26 | 2.52 ± 0.18 |
sTNFR-1 (ng/mL) | 0.33 ± 0.15* | 0.26 ± 0.06 |
IL-6 (pg/mL) | 0.14 ± 0.3 | 0.13 ± 0.02 |
Homocysteine (μmol/L) | 13.55 ± 8.3 | 16.04 ± 9.3 |
Uric acid (mg/dL) | 4.48 ± 1.2 | 4.20 ± 0.9 |
PASI: psoriasis area severity index; BMI: body mass index.
*P < 0.05; **P < 0.001.